Table 2.
Overview of sarcopenia screening results in the participants N = 200.
| Nonsarcopenic (n = 188) | Sarcopenic (n = 12) | |||
| Variables | n (%) | n (%) | t/χ2 | P value |
| Gender | ||||
| Female | 128 (68.1) | 2 (16.7) | 13.11 | .001∗∗ |
| Male | 60 (31.9) | 10 (83.3) | ||
| Age | 74.39 ± 7.26 | 83.67 ± 7.33 | −4.31 | .000∗∗ |
| 65–74 | 112 (59.6) | 1 (8.3) | 23.23 | .000∗∗ |
| 75–84 | 55 (29.3) | 4 (33.3) | ||
| > 85 | 21 (11.2) | 7 (58.3) | ||
| BMI | 25.24 ± 3.42 | 20.58 ± 2.30 | 4.65 | .000∗∗ |
| Underweight | 0 (0.0) | 2 (16.7) | 39.75 | .000∗∗ |
| Healthy | 76 (40.4) | 9 (75.0) | ||
| Overweight | 112 (59.6) | 1 (8.3) | ||
| Family history of HT | ||||
| No | 119 (63.3) | 11 (91.7) | 3.99 | .060 |
| Yes | 69 (36.7) | 1 (8.3) | ||
| History of fractures | ||||
| No | 140 (74.5) | 11 (91.7) | 1.80 | .300 |
| Yes | 48 (25.5) | 1 (8.3) | ||
| Smoking status | ||||
| No | 181 (96.3) | 10 (83.3) | 17.62 | .000∗∗ |
| Current smoker | 7 (3.7) | 2 (16.7) | ||
| Diabetes | ||||
| No | 146 (77.7) | 10 (83.3) | 0.21 | 1.000 |
| Yes | 42 (22.3) | 2 (16.7) | ||
| Fatty liver | ||||
| No | 174 (92.6) | 12 (100.0) | 0.96 | 1.000 |
| Yes | 14 (7.4) | 0 (0.0) | ||
Ps: SMI = skeletal muscle index.
∗
P value < .05.
∗∗
P value < .01.